| CRNXCrinetics Pharmaceuticals, Inc. |
7,7 mln USD |
-6046,2% |
2025 |
| CRSFCrisp Momentum Inc. |
262 USD |
-3 086 096,9% |
2025 |
| CRTOCriteo S.A. |
1,9 mld USD |
7,4% |
2025 |
| CRMLCritical Metals Corp. |
b.d. |
b.d. |
2025 |
| CROXCrocs, Inc. |
4 mld USD |
-2,0% |
2025 |
| CRONCronos Group Inc. |
193,4 mln USD |
-4,9% |
2025 |
| CAPLCrossAmerica Partners LP |
3,7 mld USD |
1,1% |
2025 |
| CRWDCrowdStrike Holdings, Inc. |
4,8 mld USD |
-3,4% |
2026 |
| CRWECrown Equity Holdings, Inc. |
777 USD |
-14 602,8% |
2025 |
| CPTKWCrown PropTech Acquisitions |
b.d. |
b.d. |
2025 |
| CRACCrown Reserve Acquisition Corp. I |
b.d. |
b.d. |
b.d. |
| CYRXCryoport, Inc. |
176,2 mln USD |
44,4% |
2025 |
| BAGZCryptex Digital Market Cap ETF |
b.d. |
b.d. |
b.d. |
| CRCWCrypto Co |
18,5 tys. USD |
-10 693,2% |
2025 |
| CSQRCsquare, Inc. |
b.d. |
b.d. |
b.d. |
| CUBECubeSmart |
1,1 mld USD |
29,7% |
2025 |
| CUECue Biopharma, Inc. |
27,5 mln USD |
-96,9% |
2025 |
| CUENCuentas Inc. |
b.d. |
b.d. |
2025 |
| CGEMCullinan Therapeutics, Inc. |
b.d. |
b.d. |
2025 |
| CULLCullman Bancorp, Inc. |
b.d. |
b.d. |
2023 |
| CMBYCumberland Farms Ltd |
b.d. |
b.d. |
b.d. |
| CUPRCuprina Holdings (Cayman) LTD |
38,8 tys. USD |
-9366,7% |
2025 |
| CURLFCuraleaf Holdings, Inc. |
1,3 mld USD |
-18,2% |
2025 |
| CURXCuranex Pharmaceuticals Inc |
b.d. |
b.d. |
2025 |
| CUBTCurative Biotechnology Inc |
b.d. |
b.d. |
b.d. |
| CURBCurbline Properties Corp. |
182,9 mln USD |
21,8% |
2025 |
| CURICuriosityStream Inc. |
71,7 mln USD |
-9,0% |
2025 |
| CURRCurrenc Group Inc. |
37,8 mln USD |
-48,7% |
2025 |
| CWKCushman & Wakefield Ltd. |
10,3 mld USD |
0,9% |
2025 |
| CTOSCustom Truck One Source, Inc. |
1,9 mld USD |
-1,6% |
2025 |
| CUBICustomers Bancorp, Inc. |
b.d. |
b.d. |
2025 |
| CYCNCyclerion Therapeutics, Inc. |
2,1 mln USD |
-170,1% |
2025 |
| CYCUCycurion, Inc. |
15,1 mln USD |
-156,4% |
2025 |
| CYNCyngn Inc. |
219 tys. USD |
-10 717,7% |
2025 |
| CTKBCytek Biosciences, Inc. |
201,5 mln USD |
-33,0% |
2025 |
| CYDYCytoDyn Inc. |
b.d. |
b.d. |
2026 |
| GDTCCytoMed Therapeutics Ltd |
252,3 tys. USD |
-1227,1% |
2025 |
| CTMXCytomX Therapeutics, Inc. |
76,2 mln USD |
-22,8% |
2025 |
| CTSOCytosorbents Corp |
37,1 mln USD |
-22,1% |
2025 |
| YCBDcbdMD, Inc. |
19,2 mln USD |
-10,6% |
2025 |